Penserra Capital Management LLC Decreases Stake in Humana Inc. (NYSE:HUM)

Penserra Capital Management LLC cut its stake in shares of Humana Inc. (NYSE:HUM) by 32.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 586 shares of the insurance provider’s stock after selling 282 shares during the period. Penserra Capital Management LLC’s holdings in Humana were worth $154,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Retirement Planning Co of New England Inc. raised its position in Humana by 4.7% during the fourth quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider’s stock valued at $245,000 after purchasing an additional 43 shares during the period. Achmea Investment Management B.V. raised its holdings in shares of Humana by 0.5% in the first quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider’s stock worth $2,746,000 after buying an additional 49 shares during the period. Beech Hill Advisors Inc. raised its holdings in shares of Humana by 6.1% in the first quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider’s stock worth $229,000 after buying an additional 50 shares during the period. Deseret Mutual Benefit Administrators raised its holdings in shares of Humana by 15.8% in the first quarter. Deseret Mutual Benefit Administrators now owns 462 shares of the insurance provider’s stock worth $122,000 after buying an additional 63 shares during the period. Finally, Vise Technologies Inc. raised its holdings in shares of Humana by 8.0% in the fourth quarter. Vise Technologies Inc. now owns 873 shares of the insurance provider’s stock worth $221,000 after buying an additional 65 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the company. Raymond James Financial raised Humana from a “market perform” rating to an “outperform” rating and set a $315.00 price objective on the stock in a research note on Thursday, May 1st. Truist Financial set a $280.00 price objective on Humana and gave the stock a “hold” rating in a research note on Tuesday, June 17th. Barclays set a $268.00 price objective on Humana and gave the stock an “equal weight” rating in a research note on Thursday, June 12th. Mizuho increased their price objective on Humana from $305.00 to $316.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 9th. Finally, Oppenheimer increased their price objective on Humana from $300.00 to $310.00 and gave the stock an “outperform” rating in a research note on Thursday, May 1st. Seventeen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, Humana has an average rating of “Hold” and a consensus target price of $280.76.

Humana Stock Down 0.8%

Humana stock opened at $230.38 on Friday. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.91 and a quick ratio of 1.91. The stock has a market capitalization of $27.81 billion, a price-to-earnings ratio of 16.29, a PEG ratio of 1.74 and a beta of 0.44. Humana Inc. has a 1-year low of $212.45 and a 1-year high of $406.46. The business has a fifty day moving average price of $237.78 and a 200-day moving average price of $258.33.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping analysts’ consensus estimates of $10.07 by $1.51. The firm had revenue of $32.11 billion during the quarter, compared to analysts’ expectations of $32 billion. Humana had a return on equity of 14.47% and a net margin of 1.42%. The business’s quarterly revenue was up 8.4% on a year-over-year basis. During the same quarter last year, the firm earned $7.23 EPS. Equities research analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a $0.885 dividend. The ex-dividend date is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a yield of 1.54%. Humana’s dividend payout ratio (DPR) is 25.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.